Session

PP 02 H. pylori (Posters)

GHRELIN AND LEPTIN FOR NON-INVASIVE DIAGNOSIS OF ADVANCED ATROPHIC GASTRITIS AND INTESTINAL METAPLASIA
GHRELIN AND LEPTIN FOR NON-INVASIVE DIAGNOSIS OF ADVANCED ATROPHIC GASTRITIS AND INTESTINAL METAPLASIA

PP 02 H. pylori (Posters)  et al.

ASSOCIATION BETWEEN HELICOBACTER PYLORI INFECTION AND NASAL POLYPS: Α SYSTEMATIC REVIEW AND META-ANALYSIS
ASSOCIATION BETWEEN HELICOBACTER PYLORI INFECTION AND NASAL POLYPS: Α SYSTEMATIC REVIEW AND META-ANALYSIS

PP 02 H. pylori (Posters)  et al.

THE EFFICACY AND SAFETY OF VONOPRAZAN IN DUAL/TRIPLE/QUADRUPLE REGIMENS BOTH IN FIRST-LINE AND RESCUE THERAPY FOR HELICOBACTER PYLORI ERADICATION: A SYSTEMATIC REVIEW WITH META-ANALYSIS
THE EFFICACY AND SAFETY OF VONOPRAZAN IN DUAL/TRIPLE/QUADRUPLE REGIMENS BOTH IN FIRST-LINE AND RESCUE THERAPY FOR HELICOBACTER PYLORI ERADICATION: A SYSTEMATIC REVIEW WITH META-ANALYSIS

PP 02 H. pylori (Posters)  et al.

IRISH HELICOBACTER PYLORI ANTIBIOTIC RESISTANCE SURVEILLANCE TO GUIDE CLINICAL PRACTICE
IRISH HELICOBACTER PYLORI ANTIBIOTIC RESISTANCE SURVEILLANCE TO GUIDE CLINICAL PRACTICE

PP 02 H. pylori (Posters)  et al.

PREVENTIVE EFFECT OF HELICOBACTER PYLORI ERADICATION ON THE ISCHEMIC STROKE AND CEREBRAL ATHEROSCLEROSIS
PREVENTIVE EFFECT OF HELICOBACTER PYLORI ERADICATION ON THE ISCHEMIC STROKE AND CEREBRAL ATHEROSCLEROSIS

PP 02 H. pylori (Posters)  et al.

EFFECTIVENESS OF THE RECOMMENDED THERAPEUTIC PROTOCOLS IN HELICOBACTER PYLORI ERADICATION: A SINGLE CENTRE TEN-YEAR EXPERIENCE
EFFECTIVENESS OF THE RECOMMENDED THERAPEUTIC PROTOCOLS IN HELICOBACTER PYLORI ERADICATION: A SINGLE CENTRE TEN-YEAR EXPERIENCE

PP 02 H. pylori (Posters)  et al.

SIXTH-LINE ERADICATION THERAPY AGAINST HELICOBACTER PYLORI INFECTION: PRELIMINARY DATA FROM THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)
SIXTH-LINE ERADICATION THERAPY AGAINST HELICOBACTER PYLORI INFECTION: PRELIMINARY DATA FROM THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)

PP 02 H. pylori (Posters)  et al.

ASSOCIATION BETWEEN HELICOBACTER PYLORI INFECTION AND GASTROESOPHAGEAL REFLUX DISEASE: MENDELIAN RANDOMIZATION STUDY
ASSOCIATION BETWEEN HELICOBACTER PYLORI INFECTION AND GASTROESOPHAGEAL REFLUX DISEASE: MENDELIAN RANDOMIZATION STUDY

PP 02 H. pylori (Posters)  et al.

EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG): ANALYSIS OF 2,254 EMPIRICAL RESCUE THERAPIES ON THIRD AND SUBSEQUENT LINES
EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG): ANALYSIS OF 2,254 EMPIRICAL RESCUE THERAPIES ON THIRD AND SUBSEQUENT LINES

PP 02 H. pylori (Posters)  et al.

CLINICAL PHENOTYPES THROUGH MACHINE LEARNING OF FIRST-LINE TREATED PATIENTS DURING THE PERIOD 2013-2022: DATA FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)
CLINICAL PHENOTYPES THROUGH MACHINE LEARNING OF FIRST-LINE TREATED PATIENTS DURING THE PERIOD 2013-2022: DATA FROM THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

PP 02 H. pylori (Posters)  et al.

CLINICOPATHOLOGICAL FEATURES AND SERUM RISK MARKERS OF METACHRONOUS GASTRIC CANCER AFTER ERADICATION
CLINICOPATHOLOGICAL FEATURES AND SERUM RISK MARKERS OF METACHRONOUS GASTRIC CANCER AFTER ERADICATION

PP 02 H. pylori (Posters)  et al.

PRESCRIPTION PATTERN OF PROBIOTICS AS AN ADJUVANT THERAPY FOR HELICOBACTER PYLORI ERADICATION: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)
PRESCRIPTION PATTERN OF PROBIOTICS AS AN ADJUVANT THERAPY FOR HELICOBACTER PYLORI ERADICATION: RESULTS OF THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)

PP 02 H. pylori (Posters)  et al.

TRENDS IN THE PRESCRIPTION OF EMPIRICAL TREATMENTS AND THEIR EFFECTIVENESS IN NAÏVE PATIENTS OVER 10 YEARS (2013-2022) IN EUROPE: DATA FROM THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)
TRENDS IN THE PRESCRIPTION OF EMPIRICAL TREATMENTS AND THEIR EFFECTIVENESS IN NAÏVE PATIENTS OVER 10 YEARS (2013-2022) IN EUROPE: DATA FROM THE EUROPEAN REGISTRY ON THE MANAGEMENT OF HELICOBACTER PYLORI INFECTION (HP-EUREG)

PP 02 H. pylori (Posters)  et al.

HELICOBACTER PYLORI AND SARS- COV-2: A DANGEROUS PATHOGENETIC CORRELATION?
HELICOBACTER PYLORI AND SARS- COV-2: A DANGEROUS PATHOGENETIC CORRELATION?

PP 02 H. pylori (Posters)  et al.

HELICOBACTER PYLORI WITH TRX1 HIGH EXPRESSION PROMOTES GASTRIC DISEASES BY UPREGULATING THE IL23A/NF-ΚB /IL8 PATHWAY
HELICOBACTER PYLORI WITH TRX1 HIGH EXPRESSION PROMOTES GASTRIC DISEASES BY UPREGULATING THE IL23A/NF-ΚB /IL8 PATHWAY

PP 02 H. pylori (Posters)  et al.

SAFETY AND EFFECTIVENESS OF VONOPRAZAN AND AMOXICILLIN DUAL REGIMEN WITH SACCHAROMYCES BOULARDII SUPPLEMENTATION AS A RESCUE THERAPY FOR HELICOBACTER PYLORI INFECTION: A PILOT STUDY
SAFETY AND EFFECTIVENESS OF VONOPRAZAN AND AMOXICILLIN DUAL REGIMEN WITH SACCHAROMYCES BOULARDII SUPPLEMENTATION AS A RESCUE THERAPY FOR HELICOBACTER PYLORI INFECTION: A PILOT STUDY

PP 02 H. pylori (Posters)  et al.

INFLUENCE OF CYTOKINE GENETIC POLYMORPHISMS IN HELICOBACTER PYLORI–ASSOCIATED GASTRIC INFLAMMATION ACCORDING TO SEX IN SOUTH KOREA
INFLUENCE OF CYTOKINE GENETIC POLYMORPHISMS IN HELICOBACTER PYLORI–ASSOCIATED GASTRIC INFLAMMATION ACCORDING TO SEX IN SOUTH KOREA

PP 02 H. pylori (Posters)  et al.

DYSPEPSIA AND PSYCHOLOGICAL STATE IN PATIENTS WITH HELICOBACTER PYLORI-ASSOCIATED CHRONIC GASTRITIS AND VIRULENCE FACTORS CAGA+, VACA+
DYSPEPSIA AND PSYCHOLOGICAL STATE IN PATIENTS WITH HELICOBACTER PYLORI-ASSOCIATED CHRONIC GASTRITIS AND VIRULENCE FACTORS CAGA+, VACA+

PP 02 H. pylori (Posters)  et al.

HELICOBACTER PYLORI INFECTION DIAGNOSIS AND MANAGEMENT: CURRENT PRACTICES OF GREEK GASTROENTEROLOGISTS
HELICOBACTER PYLORI INFECTION DIAGNOSIS AND MANAGEMENT: CURRENT PRACTICES OF GREEK GASTROENTEROLOGISTS

PP 02 H. pylori (Posters)  et al.

INCIDENCE OF HELICOBACTER PYLORI INFECTION IN GASTRIC CANCER PATIENTS IN ALBANIA: ASSOCIATION WITH HISTOPATHOLOGICAL FORMS AND CLINICAL CHARACTERISTICS - A SINGLE-CENTER STUDY
INCIDENCE OF HELICOBACTER PYLORI INFECTION IN GASTRIC CANCER PATIENTS IN ALBANIA: ASSOCIATION WITH HISTOPATHOLOGICAL FORMS AND CLINICAL CHARACTERISTICS - A SINGLE-CENTER STUDY

PP 02 H. pylori (Posters)  et al.

Item 1 - 20 / 50
1
2 3